APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $378,065 | +38.1% | 4,150 | 0.0% | 0.10% | +36.6% |
| Q1 2023 | $273,734 | +27.6% | 4,150 | 0.0% | 0.07% | +24.6% |
| Q4 2022 | $214,596 | -24.2% | 4,150 | 0.0% | 0.06% | -25.0% |
| Q3 2022 | $283,000 | +56.4% | 4,150 | +3.8% | 0.08% | +72.7% |
| Q2 2022 | $181,000 | -10.8% | 4,000 | 0.0% | 0.04% | -6.4% |
| Q1 2022 | $203,000 | +7.4% | 4,000 | 0.0% | 0.05% | +11.9% |
| Q4 2021 | $189,000 | +43.2% | 4,000 | 0.0% | 0.04% | +35.5% |
| Q3 2021 | $132,000 | -47.8% | 4,000 | 0.0% | 0.03% | -47.5% |
| Q2 2021 | $253,000 | +47.1% | 4,000 | 0.0% | 0.06% | +40.5% |
| Q1 2021 | $172,000 | -24.9% | 4,000 | 0.0% | 0.04% | -34.4% |
| Q4 2020 | $229,000 | +89.3% | 4,000 | 0.0% | 0.06% | +56.1% |
| Q3 2020 | $121,000 | -7.6% | 4,000 | 0.0% | 0.04% | -12.8% |
| Q2 2020 | $131,000 | +22.4% | 4,000 | 0.0% | 0.05% | 0.0% |
| Q1 2020 | $107,000 | – | 4,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |